Source: Times of Israel [Jerusalem]
“A novel pill helped people with advanced pancreatic cancer live longer, researchers report, raising hopes of long-needed better treatments for one of the deadliest types of cancer. ‘While not curing the cancer, it is a very large step forward,’ says Dr. Zev Wainberg, of the University of California, Los Angeles, who helped lead the study. The drug is called daraxonrasib and it blocks a mutated protein that fuels tumor growth in more than 90% of pancreatic cancer cases — a target that had eluded treatment for decades. The daily pills nearly doubled survival time, with fewer severe side effects, in a study that randomly assigned the experimental drug or more chemotherapy to 500 patients whose metastatic, or spreading, cancer had quit responding to prior treatment. The findings were published in the New England Journal of Medicine and presented at the American Society for Clinical Oncology meeting in Chicago.” (05/31/26)